In-hospital deaths and the length of stay among aspergillosis patients in the United States decreased from 2001-2011, according to recent data presented at Interscience Conference on Antimicrobial Agents and Chemotherapy in San Diego.
Researchers conducted a retrospective cross-sectional study of the incidence of mortality and burden of care associated with aspergillosis in the U.S. They examined two separate cohorts from 2001 (n = 892) and 2011 (n = 1420), each of which included all adult aspergillosis or pulmonary aspergillosis patients reported through the database for that year.
Decreases were observed in overall mortality during the later study period (18.8% vs. 7.7%; P < .0001), and persisted when limiting analysis to high- or low-risk patients. However, interaction analyses demonstrated an association between changes in mortality and certain risk groups, such as the immunocompromised.
My husband is at Community North Hospital in Indianapolis he is diagnosed with “Invasive Aspergillosis” the mold type fungus has deteriorated much of his thoracic spine. How did my husband get this in his spine? How long would he have had to have this fungal to have this damage to his spine? I am so confused how and why did my husband get this disease. Please get back to me if you have snswers.
Sincerely, Linda Snderso.